正海生物
(300653)
| 流通市值：27.41亿 | | | 总市值：27.41亿 |
| 流通股本：1.80亿 | | | 总股本：1.80亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 159,772,264.59 | 81,028,747.68 | 364,138,509.83 | 275,718,204.42 |
| 营业收入 | 159,772,264.59 | 81,028,747.68 | 364,138,509.83 | 275,718,204.42 |
| 二、营业总成本 | 130,212,995.87 | 67,086,219.15 | 290,742,077.78 | 212,425,741.37 |
| 营业成本 | 28,164,008.55 | 14,060,006.1 | 51,426,459.6 | 41,277,017.2 |
| 税金及附加 | 3,987,106.68 | 1,818,193.11 | 5,156,169.61 | 3,354,638.59 |
| 销售费用 | 59,564,006.97 | 32,266,207.36 | 142,344,653.3 | 104,892,955.22 |
| 管理费用 | 14,590,979.61 | 8,636,027.56 | 34,838,163.98 | 25,370,586.05 |
| 研发费用 | 23,998,080.14 | 10,351,566.19 | 57,326,389.63 | 37,792,293.4 |
| 财务费用 | -91,186.08 | -45,781.17 | -349,758.34 | -261,749.09 |
| 其中:利息费用 | - | - | 11,554.07 | 11,554.07 |
| 其中:利息收入 | 98,290.12 | 50,841.88 | 384,591.99 | 322,927.41 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 5,731,324.06 | 2,691,700.04 | 5,108,162.71 | 4,945,809.95 |
| 加:投资收益 | 1,139,688.76 | 363,285.32 | 8,436,117.26 | 4,099,940.62 |
| 信用减值损失(新) | -181,515.28 | -83,529.07 | -266,887.61 | -278,940.73 |
| 其他收益 | 448,311.16 | 271,875.56 | 2,553,053.94 | 1,122,340.39 |
| 四、营业利润 | 36,697,077.42 | 17,185,860.38 | 89,226,878.35 | 73,181,613.28 |
| 加:营业外收入 | 68,840.83 | 67,775.27 | 71,304.81 | 63,124.8 |
| 减:营业外支出 | 16,615.61 | 52,789.45 | 1,172,532.4 | 62,234.72 |
| 五、利润总额 | 36,749,302.64 | 17,200,846.2 | 88,125,650.76 | 73,182,503.36 |
| 减:所得税费用 | 3,443,215.77 | 2,451,577.68 | 5,715,519.06 | 5,780,307.52 |
| 六、净利润 | 33,306,086.87 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 33,306,086.87 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 33,306,086.87 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 |
| 扣除非经常损益后的净利润 | 27,157,036.26 | 12,008,081.13 | 69,663,441.33 | 59,181,608.69 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.19 | 0.08 | 0.46 | 0.37 |
| (二)稀释每股收益 | 0.19 | 0.08 | 0.46 | 0.37 |
| 九、综合收益总额 | 33,306,086.87 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 |
| 归属于母公司股东的综合收益总额 | 33,306,086.87 | 14,749,268.52 | 82,410,131.7 | 67,402,195.84 |
| 公告日期 | 2026-08-25 | 2026-04-18 | 2026-03-31 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |